COMBINED MODALITY THERAPY FOR 1ST RECURRENCE OF BREAST-CANCER - A SOUTHWEST ONCOLOGY GROUP-STUDY

被引：0
|
作者：
HOOGSTRATEN, B
GADELMAWLA, N
MALONEY, TR
FLETCHER, WS
VAUGHN, CB
TRANUM, BL
ATHENS, JW
COSTANZI, JJ
FOULKES, M
机构：
[1] BETHESDA HOSP INC,CINCINNATI,OH
[2] NATL CANC INST,CAIRO,EGYPT
[3] UNIV SO CALIF,SCH MED,LOS ANGELES,CA 90033
[4] UNIV OREGON,HLTH SCI CTR,EUGENE,OR 97403
[5] PROVIDENCE HOSP,SOUTHFIELD,MI 48037
[6] UNIV ARKANSAS MED SCI,LITTLE ROCK,AR 72205
[7] UNIV UTAH,MED CTR,SALT LAKE CITY,UT 84112
[8] UNIV TEXAS,MED BRANCH,GALVESTON,TX 77550
来源：
CANCER | 1984年 / 54卷 / 10期
关键词：
D O I：
10.1002/1097-0142(19841115)54:10<2248::AID-CNCR2820541031>3.0.CO;2-D
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2248 / 2256
页数：9
相关论文
共 50 条
  • [31] COMBINED MODALITY TREATMENT OF EXTENSIVE SMALL CELL LUNG-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY
    LIVINGSTON, RB
    MIRA, JG
    CHEN, TT
    MCGAVRAN, M
    COSTANZI, JJ
    SAMSON, M
    JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (06) : 585 - 590
  • [32] 4'-DEOXYDOXORUBICIN (DXDX) AS 1ST LINE THERAPY FOR METASTATIC BREAST-CANCER
    MARTINO, S
    SAMAL, BA
    VAITKEVICIUS, VK
    BRENNAN, MJ
    KRESGE, C
    BREAST CANCER RESEARCH AND TREATMENT, 1985, 6 (02) : 171 - 171
  • [33] RECENT PROGRESS IN BREAST-CANCER MANAGEMENT - COMBINED MODALITY (ADJUVANT) THERAPY
    COWAN, K
    LIPPMAN, M
    ARCHIVES OF INTERNAL MEDICINE, 1981, 141 (08) : 1055 - 1059
  • [34] BAKERS ANTIFOL IN CHILDREN WITH THERAPY-RESISTANT SOLID TUMORS - A SOUTHWEST ONCOLOGY GROUP-STUDY
    NITSCHKE, R
    MORGAN, SK
    LAND, VJ
    CANCER TREATMENT REPORTS, 1981, 65 (7-8): : 725 - 727
  • [35] PHASE-II EVALUATION OF HEXAMETHYLMELAMINE IN ADVANCED BREAST-CANCER - SOUTHWEST-ONCOLOGY-GROUP STUDY
    FABIAN, CJ
    RASMUSSEN, S
    STEPHENS, R
    HAUT, A
    SMITH, F
    BALCERZAK, S
    TRANUM, B
    CANCER TREATMENT REPORTS, 1979, 63 (08): : 1359 - 1361
  • [36] RANDOMIZED TRIAL OF DOXORUBICIN, BISANTRENE, AND MITOXANTRONE IN ADVANCED BREAST-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY
    COWAN, JD
    NEIDHART, J
    MCCLURE, S
    COLTMAN, CA
    GUMBART, C
    MARTINO, S
    HUTCHINS, LF
    STEPHENS, RL
    VAUGHAN, CB
    OSBORNE, CK
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (15): : 1077 - 1084
  • [37] PHASE-II TRIAL OF PIROXANTRONE IN METASTATIC BREAST-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY
    RAVDIN, PM
    GREEN, S
    DOROSHOW, JH
    MARTINO, S
    INVESTIGATIONAL NEW DRUGS, 1994, 12 (04) : 333 - 336
  • [38] BREAST-CANCER, GENETICS, AND AGE AT 1ST PREGNANCY
    LYNCH, HT
    ALBANO, WA
    LAYTON, MA
    KIMBERLING, WJ
    LYNCH, JF
    JOURNAL OF MEDICAL GENETICS, 1984, 21 (02) : 96 - 98
  • [39] PHASE-II EVALUATION OF ORAL MEDROXYPROGESTERONE ACETATE IN ADVANCED BREAST-CANCER - A NORTHERN CALIFORNIA ONCOLOGY GROUP-STUDY
    TAN, YO
    HENDRICKSON, C
    MCWHIRTER, K
    KOHLER, M
    HANNIGAN, JF
    CARLSON, RW
    CANCER TREATMENT REPORTS, 1987, 71 (10): : 969 - 970
  • [40] PHASE-II CLINICAL-TRIAL OF ACIVICIN IN ADVANCED BREAST-CANCER - AN EASTERN COOPERATIVE ONCOLOGY GROUP-STUDY
    WILLSON, JKV
    KNUIMAN, MW
    SKEEL, RT
    WOLTER, JM
    PANDYA, KJ
    FALKSON, G
    CHANG, YC
    CANCER TREATMENT REPORTS, 1986, 70 (10): : 1237 - 1238
12345